Cynk Technology Corp/ US23258A1088 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
04-08
Celularity to Present Data Showing Senescent Cell Elimination by Off-the-Shelf Natural Killer Cells ...
GlobeNewswire
2022-02-15
Celularity Receives Orphan Drug Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Develo...
GlobeNewswire
2022-01-18
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Develop...
GlobeNewswire
2021-12-27
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Develop...
GlobeNewswire
2021-12-13
Celularity Presents Preclinical Data on Allogeneic Genetically Modified Natural Killer (NK) and Allo...
GlobeNewswire
2021-11-29
Celularity Announces FDA Clearance of Investigational New Drug Application (IND) for Natural Killer ...
GlobeNewswire
2021-11-15
Celularity Presents Preclinical Data on Allogeneic Genetically-Modified Natural Killer Cells at the ...
GlobeNewswire
2021-11-12
Celularity Reports Third Quarter 2021 Financial Results and Corporate Update
GlobeNewswire
2021-09-20
Oncternal Therapeutics and Celularity Enter into Research Collaboration to Evaluate Targeted Placent...
GlobeNewswire
2021-09-20
Celularity and Oncternal Therapeutics Enter into Research Collaboration to Evaluate Targeted Placent...
GlobeNewswire
2021-07-16
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
GlobeNewswire
2021-07-07
Celularity Founder, Chairman and Chief Executive Officer, Robert J. Hariri, M.D., Ph.D., Dually Awar...
GlobeNewswire
2021-06-29
Celularity Announces Expansion of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cel...
GlobeNewswire
2021-05-20
Celularity Appoints Bradley Glover, Ph.D. as Executive Vice President and Chief Technology Officer
GlobeNewswire
2021-04-13
Celularity Receives Orphan Drug Designation for Natural Killer Cell Therapy CYNK-001 in the Treatmen...
GlobeNewswire
2021-04-09
Celularity Announces Multiple Presentations at the American Association for Cancer Research (AACR) A...
GlobeNewswire
2021-03-18
Celularity Announces Fast Track Designation by the FDA for its Natural Killer Cell Therapy CYNK-001 ...
GlobeNewswire
2020-05-21
Kleo Pharmaceuticals and Celularity Enter into Research Collaboration to Rapidly Develop Allogeneic ...
GlobeNewswire
2020-04-02
SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGIN...
GlobeNewswire
2020-01-29
Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Developmen...
GlobeNewswire
2017-03-22
Lumenis Unveils its new Moses(TM) Technology at European Association of Urology Annual Congress